Cytomegalovirus (CMV) Retinal Infection
Schedule Today
How Your Immune System Protects Your Eyes
Your immune system strength is the most important factor in preventing and controlling CMV retinitis. Understanding how your immunity affects your eye health helps us create the best prevention and monitoring plan for you while coordinating care with your other medical teams.
When your immune system works normally, it keeps CMV sleeping and harmless in your body through effective immune surveillance. But when immunity becomes severely weakened, the virus can wake up and spread to different organs, including your eyes. The weaker your immune system, especially with severe cellular immunodeficiency, the higher your risk of developing serious CMV infections with unchecked viral replication.
For people with HIV/AIDS, doctors measure immune strength using CD4 cell counts. When your CD4 count falls below 50 cells per microliter of blood, your risk for CMV retinitis increases dramatically and warrants routine retinal screening. Regular blood tests and effective HIV treatment to raise CD4 counts above 100-150 cells can significantly lower your chances of developing eye problems.
As your immune system gets stronger through proper treatment, your body regains the ability to fight CMV. Immune restoration with effective antiretroviral therapy improves viral control and allows consideration of stopping anti-CMV maintenance therapy once lesions are inactive and CD4 recovery is sustained. Sometimes, this immune recovery can actually cause inflammation in your eye, called Immune Recovery Uveitis, which our retina specialists are experts at recognizing and treating.
Expert guidance typically recommends starting antiretroviral therapy within about two weeks of beginning anti-CMV treatment. However, the exact timing should be individualized based on how threatening your lesions are, your overall health status, and your risk of complications. This careful timing helps reduce the amount of virus in your system while minimizing the risk of immune recovery uveitis.
IRU is a non-infectious inflammatory reaction that can occur after your immune system starts recovering. It can cause inflammation inside the eye and macular swelling. We manage this condition with corticosteroids while ensuring the CMV remains inactive and continuing appropriate antiviral therapy until your immune system is stable.
Regular monitoring of your immune status helps us predict and prevent CMV retinitis. We work closely with your other doctors to track important markers like CD4 counts, HIV viral loads, and overall immune function to keep your eyes as safe as possible while coordinating antiviral, antiretroviral, and immunosuppressive management.
Recognizing the Warning Signs
CMV retinitis symptoms often start mild and get worse over time, and may be subtle initially or even absent. Any new vision changes require immediate medical attention because waiting can lead to permanent retinal damage that cannot be reversed.
The first signs of CMV retinitis may include:
- Blurry, wavy, distorted, or cloudy vision that starts in one eye
- New or increased floaters that look like spots, cobwebs, or strings
- Dark or blank spots in your vision that do not go away
- Loss of side vision or difficulty seeing things out of the corner of your eye
- Problems seeing clearly in low light or at nighttime
- Straight lines that appear bent or wavy
Without proper treatment, lesions can threaten the macula or optic nerve, leading to severe central vision loss, widespread visual field defects, tunnel vision, or large blind areas. CMV retinitis typically begins in one eye but can spread to both eyes if not treated promptly, and the fellow eye may become involved over time.
Unlike some other eye infections, CMV retinitis is classically painless and usually does not cause eye pain, redness, or discomfort. This painless nature can be dangerous because you might delay seeking treatment. Any painless but progressive vision changes in people with weak immune systems should be treated as urgent until proven otherwise.
Some symptoms suggest serious complications like retinal detachment or macular involvement that need emergency treatment right away:
- Sudden bright flashes of light in your vision
- A dark shadow or curtain moving across your field of view
- Rapid worsening of vision over hours or days
- Sudden appearance of a large blind spot or newly missing section in your field of view
- Complete loss of vision in part or all of your visual field
- Sudden shower of new floaters with flashing lights
When CMV becomes active throughout your body, you might also experience fever, extreme tiredness, body aches, malaise, and general feeling of being unwell. These systemic symptoms, especially in people with compromised immunity, should be reported to your healthcare team immediately as they may indicate widespread CMV infection.
Many patients have few or no symptoms at first, which underscores the importance of scheduled dilated eye exams in high-risk groups. Regular screening helps detect lesions before they reach sight-threatening zones near the macula or optic nerve, when treatment is most effective.
Comprehensive Treatment Options
Treatment for CMV retinitis focuses on stopping the viral infection, preserving your remaining vision, and preventing complications. Our approach combines systemic antiviral medications with targeted intravitreal therapy for sight-threatening lesions, alongside coordinated immune optimization and close follow-up.
Several effective antiviral drugs can fight CMV infection, with first-line systemic therapy typically being oral valganciclovir:
- Valganciclovir: convenient oral pills with induction at 900 mg twice daily for 21 days followed by 900 mg once daily maintenance, adjusted for kidney function; monitor for low white blood cell counts, anemia, and low platelet counts
- Intravenous ganciclovir: alternative induction at specific doses every 12 hours for severe disease or poor oral tolerance
- IV foscarnet: preferred when ganciclovir resistance or intolerance occurs; requires monitoring of kidney function and electrolyte levels
- Cidofovir: administered weekly through an IV line but limited by kidney toxicity and uveitis risk; used selectively with hydration and protective medications
- Combination therapy using multiple drugs for resistant cases
For lesions threatening the macula or optic nerve, we inject antiviral medication directly into the eye to deliver high concentrations where they are needed most. These intravitreal injections are performed in our office using numbing drops and sterile techniques to maximize comfort and safety, typically alongside systemic therapy for bilateral protection:
- Ganciclovir injections given twice weekly for induction then weekly for maintenance in many protocols
- Foscarnet injections for induction then weekly maintenance, useful for resistant cases or drug intolerance
- Treatment schedules vary with disease activity and are tapered as borders become inactive and lesions stabilize
When CMV retinitis causes complications, surgical procedures may be necessary:
- Vitrectomy surgery to remove infected gel, repair retinal damage, or address non-clearing vitreous opacities, often with tamponade agents like silicone oil in complex cases
- Prompt retinal detachment repair using gas bubbles, silicone oil, or laser treatment, which improves prognosis but requires careful postoperative monitoring
- Laser photocoagulation to seal leaking blood vessels
- Cataract surgery if medications cause lens clouding
- Glaucoma procedures if eye pressure becomes elevated
Close monitoring includes frequent eye exams during treatment, periodic labs for blood cell counts and kidney function, and serial imaging to detect early relapse or complications:
- Weekly exams during induction phase, then at two weeks post-induction, followed by monthly visits while on treatment
- Complete blood count and kidney function tests at defined intervals depending on the antiviral used and your other health conditions
- Regular imaging studies to track changes and watch for complications like macular swelling
Successful treatment requires close cooperation with your other doctors. We work with your HIV specialist, transplant team, or oncologist to optimize your immune system while safely treating the eye infection. Outcomes improve when retinal care is aligned with HIV treatment optimization or transplant medicine protocols to balance viral suppression and immunosuppression safely.
CMV retinitis treatment typically occurs in two phases. The induction phase uses higher doses of antiviral drugs for several weeks to quickly control the active infection. The maintenance phase continues with lower doses or less frequent treatments to prevent the infection from returning while your immune system recovers.
After lesion inactivity, chronic maintenance can be stopped when your CD4 count is greater than 100-150 cells per microliter for 3-6 months with suppressed HIV viral load and reliable follow-up. Treatment may need to be re-started if CD4 falls or activity returns.
If we suspect resistance to treatment, we consider switching to different classes of medications, using combination regimens, and molecular testing when available to guide the best therapy for your specific situation.
Prevention and Risk Reduction
While CMV retinitis cannot always be prevented, several strategies can significantly reduce your risk and help catch the condition early when treatment is most effective. Prevention focuses on maintaining or restoring immune function and screening those at highest risk.
The best way to prevent CMV retinitis is keeping your immune system as strong as possible:
- Taking HIV medications exactly as prescribed to maintain low viral loads and CD4 counts above 100 cells per microliter
- Following transplant medication schedules carefully with your doctors and coordinating CMV prevention protocols
- Getting regular check-ups to monitor your immune status
- Staying up to date with recommended vaccinations when safe
- Maintaining good nutrition and getting adequate rest
- Practicing good hygiene to reduce exposure to other CMV strains during immunosuppression
People at high risk need regular dilated eye exams even without symptoms because early CMV retinitis can be asymptomatic:
- At least every three months for people with CD4 counts below 50 cells per microliter
- Every 6 weeks for those with extremely low immune function
- More frequent exams during periods of immune suppression or if lesions are near the macula or optic nerve
- Baseline eye exams before starting immunosuppressive treatments when possible
- Immediate evaluation for any new vision symptoms
Transplant patients often receive CMV prophylaxis according to organ-specific protocols. However, primary prophylaxis to prevent CMV retinitis is generally not recommended in HIV patients on effective antiretroviral therapy and should be individualized to systemic indications rather than eye risk alone.
The location of CMV lesions matters significantly for treatment decisions. Lesions in Zone 1 near the macula or optic disc threaten vision immediately and require more aggressive local therapy and monitoring compared with peripheral Zone 2 or 3 disease, which poses less immediate risk to central vision.
Optimizing HIV control, carefully adjusting immunosuppressive medication regimens when safe, and promptly treating systemic CMV disease all reduce your eye risk and support long-lasting remission of the retinal infection.
Work with your healthcare team to understand your specific risk level based on your underlying condition, current immune status, medication regimen, and other health factors. This personalized risk assessment helps determine the best screening and prevention strategy for your individual situation.
Long-Term Management and Follow-Up
Living successfully with CMV retinitis requires ongoing medical care, regular monitoring, and sometimes lifestyle adjustments to maintain your vision and quality of life. Comprehensive care includes ongoing follow-up, therapy adherence, and low-vision support when needed.
Managing CMV retinitis works best with a coordinated team approach. Your retina specialist works closely with your primary care doctor, HIV specialist, infectious disease team, transplant coordinator, oncologist, or other specialists to ensure all aspects of your health are addressed together for the best possible outcomes and to balance antiviral therapy with your other treatments.
After initial treatment, you will need regular follow-up visits to watch for disease recurrence and complications:
- Weekly or bi-weekly visits during the acute induction and consolidation treatment phases
- Monthly maintenance visits while on suppressive therapy, typically every 4-6 weeks
- Every 2 to 3 months once your immune system recovers, then spaced based on stability
- Annual comprehensive eye exams for long-term monitoring
- Immediate evaluation if new symptoms develop
- Ongoing screening for retinal detachment and macular swelling
Taking your antiviral medications exactly as prescribed and keeping all appointments is crucial for controlling CMV retinitis. Taking antivirals exactly as prescribed is essential to halt progression, prevent resistance, and protect vision long-term. Never stop or change your antiviral medications without talking to your doctor first, even if you feel better.
Some patients may experience permanent vision changes that require simple adjustments and tools to help maintain independence:
- Using brighter enhanced task lighting for reading and close work
- Learning to use low vision aids, magnifying devices, and assistive technology
- Organizing your home environment for safety and independence if peripheral vision is affected
- Using high-contrast materials, large-print resources, and smartphone apps
- Modifying driving habits or exploring alternative transportation options as needed
- Safety planning for mobility and home environments
Our practice can connect you with specialized services to help maximize your remaining vision and maintain independence. Low-vision rehabilitation offers training and tools to maximize remaining sight, improve reading and mobility, and support daily task performance. Vision rehabilitation professionals teach practical strategies for daily activities and introduce assistive technologies that can significantly improve your quality of life.
Coping with vision changes and chronic illness can be emotionally challenging. Support resources include:
- Counseling services for coping and adjustment strategies
- Support groups for people with vision loss and connecting with others who have similar experiences
- Social work services to address practical challenges of living with a chronic retinal condition
- Access to low-vision specialists and community resources for assistive technology
With individualized safety counseling, visual rehabilitation, and thoughtful decision-making based on measured visual function, most patients can resume many daily activities and maintain a good quality of life. We provide guidance on safe return-to-driving decisions and help you adapt to any vision changes.
Frequently Asked Questions
Here are answers to the most common questions our patients ask about CMV retinitis, its treatment, and what to expect during your care with us.
CMV retinitis specifically affects people with severely weakened immune systems and has a characteristic appearance that our retina specialists can recognize. It is a viral necrotizing retinitis with distinctive hemorrhagic, granular lesions, whereas bacterial, fungal, or other herpetic infections have different clinical patterns and treatment approaches. Unlike bacterial or fungal eye infections that can affect anyone, CMV retinitis almost exclusively occurs in immunocompromised patients.
Treatment can effectively control the active infection and prevent further vision loss, but it does not permanently eliminate CMV from your body. Therapy suppresses viral replication and halts progression but does not eradicate latent CMV, so relapse can occur if your immune system becomes severely weakened again in the future. This is why ongoing monitoring remains important even after successful treatment.
Treatment duration varies significantly between patients. Induction typically lasts about three weeks, followed by maintenance treatment until your immune system becomes strong enough to control CMV naturally and lesions are inactive. Some patients may require maintenance therapy for many months or even years, with timing individualized to disease location, systemic status, and CD4 recovery sustained for 3-6 months.
Treatment aims to preserve your remaining vision and prevent further damage, but it cannot restore vision that was already lost due to permanent retinal damage. Sight lost from necrotic retinal areas cannot be restored, making early detection and prompt therapy crucial. Areas of the retina that are still healthy can often be saved with appropriate therapy.
CMV retinitis does increase the risk of retinal detachment because the infection weakens retinal tissue and can create tears or holes. Necrotic retina predisposes to retinal detachment, particularly with extensive involvement. Retinal detachment is a serious complication that requires emergency surgery, but our specialists watch carefully for early signs and can often prevent detachment with prompt intervention.
Antiviral medications can cause various side effects that we monitor carefully. Common issues include:
- Decreased white blood cell counts and anemia with valganciclovir/ganciclovir that may increase infection risk
- Potential effects on kidney function requiring blood test monitoring, especially with foscarnet
- Digestive problems including nausea, diarrhea, or stomach upset
- Fatigue, headaches, or general feeling of being unwell
- Electrolyte disturbances with certain medications
- Possible interactions with other medications you may be taking
Yes, routine eye screening is extremely important for anyone with a significantly weakened immune system, even without symptoms. People with HIV and CD4 counts below 50 cells per microliter should have dilated exams at least every three months, and anyone with new visual symptoms needs immediate evaluation regardless of schedule. Early detection of CMV retinitis greatly improves treatment outcomes.
Pregnant women with active CMV infection can pass the virus to their unborn babies, potentially causing congenital CMV infection. Active maternal CMV can transmit to infants and, rarely, involve the retina. Babies born with CMV may develop retinal problems and other complications. Pregnant patients need specialized care coordinating between maternal-fetal medicine specialists and retina experts to optimize outcomes.
Your ability to drive safely depends on how much vision remains and which areas of your retina are affected. Driving depends on visual acuity and visual fields relative to local legal requirements. We perform comprehensive visual field testing and assess your functional vision to help determine driving safety. Some patients may need to modify their driving habits or explore alternative transportation options based on formal testing and individualized counseling.
Most health insurance plans, including Medicare and Medicaid, provide coverage for medically necessary CMV retinitis diagnosis and treatment. This includes medications, office visits, diagnostic testing, injections, and surgical procedures when needed. Medically necessary diagnostics, medications, injections, and surgeries are typically covered under most plans, with prior authorizations handled case-by-case by our care teams to minimize your out-of-pocket costs.
Yes, CMV retinitis can recur if your immune system becomes severely suppressed again. Relapse can occur if immune function declines, which is why maintaining good immune function through proper medical care and regular monitoring are so important. Recurrence is usually treatable, but it emphasizes the importance of staying connected with your healthcare team long-term and continuing follow-up even after maintenance antivirals are stopped.
In most cases, antiretroviral therapy should be started within about two weeks after initiating anti-CMV therapy, though the exact timing should be individualized. This timing helps reduce the amount of virus in your system and restore immune control while minimizing the risk of immune recovery uveitis. The decision is coordinated between your retina specialist and HIV care team based on your specific situation.
It is extremely rare for people with normal immune systems to develop CMV retinitis, though cases have been reported with local ocular immunosuppression from steroid eye drops or unique host factors. The vast majority of patients have systemic or local immunosuppression that allows CMV to reactivate and cause retinal infection. While exceedingly rare, it is not impossible in certain circumstances.
Research into CMV retinitis treatment continues, and new approaches are occasionally developed. Our retina specialists stay current with the latest advances and clinical trials. We can discuss whether any investigational treatments might be appropriate for your specific situation if standard therapies are not sufficient or if you have resistant disease.
Missing doses can allow the virus to become active again and potentially develop resistance to treatment. If you accidentally miss a dose, take it as soon as you remember, unless it is almost time for your next dose. Never double up on doses without consulting your doctor. Contact your healthcare team immediately if you have concerns about missed medications or side effects that prevent you from taking your prescribed treatment.
For sight-threatening lesions near the macula or optic nerve, intravitreal injections are typically given twice weekly during induction, then weekly during maintenance. The exact schedule depends on how your lesion responds to treatment and may be adjusted based on disease activity. Most patients find the injections tolerable with numbing drops, and the frequency decreases as the infection becomes inactive.
Expert Retinal Care When You Need It Most
If you have a condition that weakens your immune system and notice any changes in your vision, contact Retina Consultants, PA immediately. Our fellowship-trained retina specialists at our Ridgewood, Belleville, and Jersey City locations provide prompt, expert evaluation and the most advanced treatments available to protect your sight, preserve your independence, and coordinate with your other medical teams for comprehensive care.